Literature DB >> 9625336

Factors influencing the spread of pertussis in households.

C H Wirsing von König1, S Postels-Multani, H Bogaerts, H L Bock, S Laukamp, S Kiederle, H J Schmitt.   

Abstract

UNLABELLED: The objective of this study was to compare the spread of pertussis in children and adults being secondary contacts after household exposure. The study was nested in an efficacy trial of an acellular pertussis vaccine. The spread of the disease was also monitored with respect to gender and antibiotic therapy. A total of 453 index cases, of which 133 were monitored for adult disease, fulfilled the WHO definition of pertussis. They had contacts to 173 unvaccinated children aged 6-47 months, and a total of 101 adults with pertussis were followed. Detection of the bacteria, or a significant increase of specific antibodies confirmed the diagnosis. Secondary spread of the disease was assumed, when a household member coughed for 7 days or more and had laboratory evidence for pertussis. Crude attack rates (AR) were 69% in children and 31% in adults (P < 0.05). AR in children were independent of gender but more women than men (P=0.02) were affected in those households where the index case was a child. Erythromycin treatment of the index case reduced the AR in exposed toddlers from 80% to 57% (P=0.06), and in exposed adults from 40% to 21% (P=0.2). Erythromycin therapy in contacts did not alter the clinical course of the disease significantly.
CONCLUSIONS: In a household study of pertussis, 69% of children and 31% of adults (more women than men) contracted the disease. Erythromycin reduced the number of infections in household contacts, but did not alter the clinical course in those who contracted pertussis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625336     DOI: 10.1007/s004310050836

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  An Epidemiological Study of an Outbreak of Pertussis in a Public School.

Authors:  A C Rodman; W L Bradford; G P Berry
Journal:  Am J Public Health Nations Health       Date:  1946-10

Review 2.  Pertussis and its prevention: a family affair.

Authors:  E A Mortimer
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

3.  Protection against pertussis by acellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan.

Authors:  T Kato; T Goshima; N Nakajima; H Kaku; Y Arimoto; F Hayashi
Journal:  Acta Paediatr Jpn       Date:  1989-12

4.  The efficacy of pertussis vaccines under conditions of household exposure. Further analysis of the 1978-80 PHLS/ERL study in 21 area health authorities in England.

Authors:  P E Fine; J A Clarkson; E Miller
Journal:  Int J Epidemiol       Date:  1988-09       Impact factor: 7.196

5.  Sensitivity and specificity of clinical case definitions for pertussis.

Authors:  P A Patriarca; R J Biellik; G Sanden; D G Burstyn; P D Mitchell; P R Silverman; J P Davis; C R Manclark
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

6.  Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany.

Authors:  U Heininger; J D Cherry; T Eckhardt; C Lorenz; P Christenson; K Stehr
Journal:  Pediatr Infect Dis J       Date:  1993-06       Impact factor: 2.129

7.  Seroepidemiology of pertussis in Italy.

Authors:  A Giammanco; A Chiarini; T Stroffolini; D De Mattia; M Chiaramonte; M E Moschen; I Mura; G Rigo; S Taormina; A Sarzana
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

8.  Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan.

Authors:  S Isomura
Journal:  Dev Biol Stand       Date:  1991

9.  Efficacy of an acellular pertussis vaccine in Japan.

Authors:  T Aoyama; Y Murase; T Kato; T Iwata
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

10.  Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.

Authors:  R W Steketee; S G Wassilak; W N Adkins; D G Burstyn; C R Manclark; J Berg; D Hopfensperger; W L Schell; J P Davis
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

View more
  10 in total

Review 1.  Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix).

Authors:  Therese M Chapman; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013.

Authors:  Pere Godoy; Manuel García-Cenoz; Diana Toledo; Glòria Carmona; Joan A Caylà; Miquel Alsedà; Josep Àlvarez; Irene Barrabeig; Neus Camps; Pere Plans; María Company; Jesús Castilla; Maria-Rosa Sala-Farré; Carmen Muñoz-Almagro; Cristina Rius; Àngela Domínguez
Journal:  Euro Surveill       Date:  2016-11-10

4.  Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background.

Authors:  R Gonzales; J G Bartlett; R E Besser; R J Cooper; J M Hickner; J R Hoffman; M A Sande
Journal:  Ann Emerg Med       Date:  2001-06       Impact factor: 5.721

Review 5.  Management of acute bronchitis in healthy adults.

Authors:  Eva Aagaard; Ralph Gonzales
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

6.  ARIMA and ARIMA-ERNN models for prediction of pertussis incidence in mainland China from 2004 to 2021.

Authors:  Meng Wang; Jinhua Pan; Xinghui Li; Mengying Li; Zhixi Liu; Qi Zhao; Linyun Luo; Haiping Chen; Sirui Chen; Feng Jiang; Liping Zhang; Weibing Wang; Ying Wang
Journal:  BMC Public Health       Date:  2022-07-29       Impact factor: 4.135

7.  Infant pertussis and household transmission in Korea.

Authors:  Hyo Jin Kwon; Sook Kyung Yum; Ui Yoon Choi; Soo Young Lee; Jong Hyun Kim; Jin Han Kang
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

8.  The epidemiology of pertussis in Germany: past and present.

Authors:  Wiebke Hellenbrand; Dietmar Beier; Evelin Jensen; Martina Littmann; Christiane Meyer; Hanna Oppermann; Carl-Heinz Wirsing von König; Sabine Reiter
Journal:  BMC Infect Dis       Date:  2009-02-25       Impact factor: 3.090

9.  Bordetella pertussis in children hospitalized with a respiratory infection: clinical characteristics and pathogen detection in household contacts.

Authors:  Juana Del Valle-Mendoza; Wilmer Silva-Caso; Miguel Angel Aguilar-Luis; Cristina Del Valle-Vargas; Erico Cieza-Mora; Johanna Martins-Luna; Ronald Aquino-Ortega; Andrea Silva-Vásquez; Jorge Bazán-Mayra; Pablo Weilg
Journal:  BMC Res Notes       Date:  2018-05-18

10.  Tracheal colonization factor A (TcfA) is a biomarker for rapid and specific detection of Bordetella pertussis.

Authors:  Amanda R Burnham-Marusich; Ryan K Olsen; Jacqueline Scarbrough; Alexander Kvam; Wei Yang; Lindsey Zimmerman; James J Dunn; Tod Merkel; Thomas R Kozel
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.